Prolonged adverse events following photodynamic therapy: regulatory implications.

Abstract

OBJECTIVE To determine whether field photodynamic therapy (PDT) of actinic keratoses (AKs) using a novel preparation of 5-aminolevulonic acid (ALA) would result in fewer subsequent invasive skin cancers developing on the face. DESIGN A prospective multi-center randomized controlled trial. The protocol was approved by the Bond University Human Research… (More)

Topics

Cite this paper

@article{Anderson2014ProlongedAE, title={Prolonged adverse events following photodynamic therapy: regulatory implications.}, author={Stuart J. Anderson and Howard K Steinman and Jason D Mazzurco and Anthony J Dixon}, journal={Journal of drugs in dermatology : JDD}, year={2014}, volume={13 1}, pages={62-6} }